Registry and biorepository for pulmonary hypertension patients
Pulmonary Hypertension Biorepository and Registry
University of Kansas Medical Center · NCT04808596
This study is setting up a collection of health information and blood samples from people with pulmonary hypertension to help researchers learn more about the disease and improve treatments.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Kansas Medical Center (other) |
| Locations | 1 site (Kansas City, Kansas) |
| Trial ID | NCT04808596 on ClinicalTrials.gov |
What this trial studies
This project aims to establish a comprehensive registry and biorepository of blood samples from patients diagnosed with pulmonary hypertension across various classifications. It will include both retrospective and prospective data collection to enhance understanding of the disease's cellular mechanisms and mediators. The collected samples will be utilized for future research, potentially leading to advancements in treatment options for pulmonary hypertension. The study will involve patients from the University of Kansas Medical Center.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a confirmed diagnosis of pulmonary hypertension.
Not a fit: Patients who decline to participate or are unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the understanding and treatment of pulmonary hypertension.
How similar studies have performed: While this approach is not novel, similar studies have successfully established registries and biorepositories that have contributed to advancements in understanding various diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP) 2. The participant has a diagnosis of pulmonary hypertension confirmed by right heart catheterization 3. Patient is ≥ 18 years of age or older Exclusion Criteria: 1. Participant declines to participate (living patients only) 2. Participant is unable to provide informed consent (living patients only)
Where this trial is running
Kansas City, Kansas
- University of Kansas Medical Center — Kansas City, Kansas, United States (RECRUITING)
Study contacts
- Principal investigator: Leslie A Spikes, MD — Assistant Professor of Medicine
- Study coordinator: Luigi R Boccardi, Ed.D., MPH
- Email: lboccardi@kumc.edu
- Phone: 9135884022
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pulmonary Hypertension, Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Left Heart Disease, Pulmonary Hypertension, Primary, Pulmonary Hypertension Due to Lung Diseases and Hypoxia, Pulmonary Hypertension, Primary, 4, Pulmonary Hypertension, Primary, 2, Pulmonary Hypertension, Primary, 3